Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration
Completed · Phase 1/Phase 2
Conditions studied: Rheumatoid Arthritis
In brief
Pharmacokinetics (PK) study
Key facts
- Study ID
- NCT01737944
- Run by
- Antares Pharma Inc.
- People needed
- 38
- Starts
- 2011-01-01
- Expected to finish
- 2011-06-01
- Last updated by the study team
- 2014-02-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female >18 years of age with diagnosed Rheumatoid Arthritis(RA).
You may not qualify if…
- Chronic or acute renal disease
- Any other clinically significant disease or disorder which, in the opinion of the investigator, might put the subject at risk
Where it is running
- Altoona Center for Clinical Research — Duncansville, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.